Jounce Therapeutics, Inc.

GEODE CAPITAL MANAGEMENT, LLC

Report date

3/31/2023

Quarter

2023 Q1

Filed

5/15/2023

Shares

767,117

Value ($000)

1,419

Weight

0.0%

2019 Q4 - 2023 Q1 (14 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q1	5/15/2023	1,419	0.0%	767,117	3/31/2023
2022 Q4	2/13/2023	744	0.0%	670,462	12/31/2022
2022 Q3	11/14/2022	1,538	0.0%	657,282	9/30/2022
2022 Q2	8/12/2022	1,891	0.0%	624,275	6/30/2022
2022 Q1	5/13/2022	4,051	0.0%	596,615	3/31/2022
2021 Q4	2/11/2022	5,201	0.0%	622,876	12/31/2021
2021 Q3	11/12/2021	4,565	0.0%	614,430	9/30/2021
2021 Q2	8/13/2021	3,600	0.0%	529,515	6/30/2021
2021 Q1	5/12/2021	3,517	0.0%	342,525	3/31/2021
2020 Q4	2/12/2021	1,870	0.0%	267,307	12/31/2020
2020 Q3	11/13/2020	2,145	0.0%	262,940	9/30/2020
2020 Q2	8/13/2020	1,698	0.0%	246,144	6/30/2020
2020 Q1	5/14/2020	1,175	0.0%	247,528	3/31/2020
2019 Q4	2/13/2020	2,268	0.0%	259,960	12/31/2019